| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc69cb952a3c65d4a06cd53c5448175e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a86803a83b5fa8c5b89fad522af03a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_95868a67bc734c4e8f2b1fea138a7e06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa943761d4509ded457462a55fdb7416 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70596 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2000-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7407a99c9b8cd52da81aabc379e02746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90fc2713818ae8ac010ce088ab581e55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc3ba9b799a13eb4f73c82b8725b04f |
| publicationDate |
2001-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0110205-A1 |
| titleOfInvention |
Methods and materials relating to cd39-like polypeptides |
| abstract |
The invention provides novel polynucleotides isolated from cDNA libraries of human fetal liver-spleen and macrophage as well as polypeptides encoded by these polynucleotides and mutants or variants thereof. The polypeptides correspond to a novel human CD39-like protein. Other aspects of the invention include vectors containing polynucleotides of the invention and related host cells as well as processes for producing novel CD39-like polypeptides, and antibodies specific for such polypeptides. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2075256-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006046411-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492383-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017220988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017220989-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017220990-A1 |
| priorityDate |
1999-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |